Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67 USD | +0.07% |
|
-1.46% | +116.20% |
06-21 | Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating | MT |
06-20 | JPMorgan Raises Insmed's Price Target to $72 From $55, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+116.20% | 10.8B | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Transcript : Insmed Incorporated, Q4 2023 Earnings Call, Feb 22, 2024